Cipla gets USFDA nod for overactive bladder treating drug

"We have received final approval for ANDA for Darifenacin extended-release tablets, 7.5 mg and 15mg, from USFDA," a company statement said here.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news